Dopamine antagonist with selectivity for D2
-like receptors (Ki
values are 1.2, ~ 7, 2.3, ~ 80 and ~ 100 nM for D2
receptors respectively). Subtype-selective NMDA antagonist.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Kishimoto T et al.
Leucocyte Typing VI. Garland Publishing Inc. London.
Haloperidol decanoate. A preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in psychosis.
Beresford and Ward
Subtype-selective inhibition of N-methyl-D-aspartate receptors by haloperidol.
IIyin et al.
Inhibition of N-methyl-D-aspartate receptors by haloperidol: development and pharmacological characterization in native and recombinant receptors.
Lynch and Gallagher
Dopamine receptor pharmacology.
Seeman and Van Tol
Trends Pharmacol.Sci., 1994;15:264
The citations listed below are publications that use Tocris products. Selected citations for Haloperidol hydrochloride include:
Showing Results 1 - 7 of 7